HAROLD ZYLICZ: Open Payments
NPI 1366096950 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$901 in 41 payments from 8 companies in 2025. Trend: 2023 $817 · 2024 $564 · 2025 $901
Food & beverage: $901
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 13 | $266 |
| Optinose US, Inc. | 11 | $259 |
| GENZYME CORPORATION | 7 | $165 |
| Regeneron Healthcare Solutions, Inc. | 6 | $137 |
| AERIN MEDICAL INC. | 1 | $27 |
| Hikma Pharmaceuticals USA | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
Products named: DUPIXENT, Xhance, NUCALA, VIVAER STYLUS, TRELEGY ELLIPTA, Ryaltris, TEZSPIRE.
Industry payments across LA — which companies pay providers there.
